Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantation

Am J Transplant. 2009 Nov;9(11):2542-51. doi: 10.1111/j.1600-6143.2009.02797.x.

Abstract

It has been suggested that dual kidney transplantation (DKT) improves outcomes for expanded criteria donor (ECD) kidneys. However, no criteria for allocation to single or dual transplantation have been assessed prospectively. The strategy of DKT remains underused and potentially eligible kidneys are frequently discarded. We prospectively compared 81 DKT and 70 single kidney transplant (SKT) receiving grafts from ECD donors aged >65 years, allocated according to donor estimated glomerular filtration rate (eGFR): DKT if eGFR between 30 and 60 mL/min, SKT if eGFR greater than 60 mL/min. Patient and graft survival were similar in the two groups. In the DKT group, 13/81 patients lost one of their two kidneys due to hemorrhage, arterial or venous thrombosis. Mean eGFR at month 12 was similar in the DKT and SKT groups (47.8 mL/min and 46.4 mL/min, respectively). Simulated allocation of kidneys according to criteria based on day 0 donor parameters such as those described by Remuzzi et al., Andres et al. and UNOS, did not indicate an improvement in 12-month eGFR compared to our allocation based on donor eGFR.

MeSH terms

  • Age Factors
  • Aged
  • Biopsy
  • Delayed Graft Function / mortality
  • Delayed Graft Function / pathology
  • Delayed Graft Function / prevention & control
  • Female
  • Glomerular Filtration Rate*
  • Graft Rejection / mortality
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control
  • Graft Survival
  • Humans
  • Kaplan-Meier Estimate
  • Kidney / pathology
  • Kidney / physiology
  • Kidney Transplantation / methods*
  • Kidney Transplantation / mortality*
  • Logistic Models
  • Male
  • Middle Aged
  • Postoperative Complications / mortality
  • Primary Graft Dysfunction / mortality*
  • Primary Graft Dysfunction / pathology
  • Primary Graft Dysfunction / prevention & control*
  • Prognosis
  • Tissue Donors*
  • Tissue and Organ Procurement